Fang-Zheng Wang

Fragmented QRS is associated with all-cause mortality and ventricular arrhythmias in patient with idiopathic dilated cardiomyopathy.

Background: Several studies have showed that fragmented QRS complexes (f ‐ QRS, defined as different RSR′ patterns) on a routine 12 ‐ lead electrocardiogram were associated with increased mortality and arrhythmic events in patients with coronary artery disease, but relatively little data were available regarding idiopathic dilated cardiomyopathy (IDCM).

Perioperative anticoagulation for patients with mechanic heart valve(s) undertaking pacemaker implantation

AIMS This study was to evaluate perioperative anticoagulation therapy in patients with mechanic heart valve(s) undergoing pacemaker implantation. METHODS AND RESULTS A total of 109 patients with mechanical heart valve(s) undertaking pacemaker implantation were studied. Fifty-one patients with warfarin suspended 3 days before surgery were classified into Group 1 and 58 patients with warfarin suspended <3 days or not at all into Group 2. The perioperative incidence of complications was compared. Suspension of warfarin<3 days before surgery was associated with a higher incidence of excessive haemorrhage (16/51 vs. 5/58, P=0.003). Patients with pocket haematoma were more likely to have been treated with post-operation heparin (60% vs. 17.3%, P=0.032). In 42 patients treated with proposed protocol of perioperative anticoagulation, no pocket haematoma or embolism occurred. CONCLUSIONS A minimum of 3 days cessation of warfarin prior to surgery is preferred. Low-molecular-weight heparin should not be used for at least 3 days post-surgery. We propose that the protocol of perioperative anticoagulation be a suspension of warfarin not <3 days with low-molecular-weight heparin bridging stopped 12 h before surgery, and warfarin rather than low-molecular-weight heparin initiated immediately after surgery.

Inflammation in Lone Atrial Fibrillation

This study was designed to evaluate the correlation between lone atrial fibrillation and inflammation.

Improvement of P wave dispersion after cardiac resynchronization therapy for heart failure

OBJECTIVE The purpose of this study is to investigate the effect of cardiac resynchronization therapy (CRT) on P wave maximum duration (PWM) and P wave dispersion (PWD) in patients with advanced heart failure. METHODS Forty-six patients (33 men; mean age, 60 +/- 11 years) with CRT were enrolled in the present study. PWM and PWD were measured using 12-lead surface electrocardiography (ECG) at a paper speed of 50 mm/s and 20 mm/mV. Serial ECG, echocardiography, clinical assessment, and device interrogations were performed at baseline and 3 months after CRT. RESULTS After 3 months of follow-up, PWM and PWD values were significantly decreased (129.6 +/- 11.3 to 120.7 +/- 10.7 milliseconds, P < .001; 42.6 +/- 8.0 to 32.3 +/- 10.1 milliseconds; P < .001, respectively). It showed a significant reduction in left atrial diameter (LAD) (46.5 +/- 5.2 to 44.9 +/- 5.6 mm, P = .021) and an improvement in left ventricular ejection fraction (LVEF) (29.0% +/- 7.5% to 36.2% +/- 8.0%, P < .001). The decrease of PWM and PWD was positively correlated with the reduction of LAD and negatively correlated with the improvement of LVEF. The reduction in atrial fibrillation burden was observed after 3 months of follow-up. CONCLUSIONS Cardiac resynchronization therapy decreases PWM and PWD along with an improvement of LVEF and a reduction of LAD. Further studies are needed to evaluate the clinical implications of decrease of PWD on prevention of atrial fibrillation.